CD84 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD84 monoclonal antibodies for advanced research in immunology and cell biology. CD84 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD84 is a member of the signaling lymphocytic activation molecule (SLAM) family and plays a crucial role in immune cell interactions and activation. CD84 is primarily expressed on the surface of immune cells, including T cells and B cells, and is involved in regulating immune responses, making it essential for maintaining immune homeostasis. The study of CD84 has revealed important insights into immune system function and regulation. Understanding CD84's role in cellular communication has opened new avenues for investigating immune disorders. Research focusing on CD84 continues to advance our knowledge of immune cell signaling pathways and their implications in health and disease. CD84 investigation has become increasingly important for developing new therapeutic strategies for autoimmune conditions and inflammatory diseases. Santa Cruz Biotechnology monoclonal antibodies for CD84 research support scientists worldwide in advancing our understanding of immune system function and developing innovative therapeutic approaches.